Atom Investors’s NeoGenomics NEO Stock Holding History

Atom Investors’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-15,791	Closed	-$115K	–	752
2025 Q2	$115K	Buy	+15,791	New	+$127K	0.01%	544
2022 Q3	–	Sell	-13,530	Closed	-$110K	–	337
2022 Q2	$110K	Buy	+13,530	New	+$129K	0.05%	215

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Atom Investors's NEO Position: Q3 2025 in Review

Atom Investors sold out of NeoGenomics (NEO) in Q3 2025, closing a stake of 15,791 shares — an estimated $115K sold.

Atom Investors first reported a position in NEO in Q2 2022 and held it in 2 quarters. The position peaked at $115K in Q2 2025. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

Atom Investors reported no remaining NeoGenomics position as of Q3 2025 after selling out during the quarter.
Atom Investors sold 15,791 NeoGenomics shares in Q3 2025, an estimated $115K.
Atom Investors first reported a position in NeoGenomics in Q2 2022 and held it in 2 quarters.
Atom Investors's NeoGenomics position peaked at $115K in Q2 2025.
254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on Atom Investors's 13F filing for Q3 2025, filed 14 Nov 2025.